The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of QOL deterioration during early lung cancer survivorship: Secondary analysis of RTOG 0212 and 0214.
V. Gondi
No relevant relationships to disclose
R. Paulus
No relevant relationships to disclose
D. Bruner
No relevant relationships to disclose
C. A. Meyers
No relevant relationships to disclose
E. Gore
No relevant relationships to disclose
A. H. Wolfson
Consultant or Advisory Role - Bio-Nucleonics
M. Werner-Wasik
No relevant relationships to disclose
H. Choy
No relevant relationships to disclose
B. Movsas
No relevant relationships to disclose